These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38232513)

  • 1. CXCL16 promotes tumor metastasis by regulating angiogenesis in the tumor micro-environment of BRAF V600E mutant colorectal cancer.
    Deng W; Liu X; Huang S; Wu Z; Alessandro F; Lin Q; Cai Z; Zhang Z; Huang Y; Wang H; Yuan Z
    Transl Oncol; 2024 Mar; 41():101854. PubMed ID: 38232513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF
    Zhi J; Jia XJ; Yan J; Wang HC; Feng B; Xing HY; Jia YT
    World J Gastrointest Oncol; 2021 Dec; 13(12):2129-2148. PubMed ID: 35070047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of BRAF Non-V600E Mutations in Colorectal Cancer: A Retrospective Study of Two Institutions.
    Shimada Y; Tajima Y; Nagahashi M; Ichikawa H; Oyanagi H; Okuda S; Takabe K; Wakai T
    J Surg Res; 2018 Dec; 232():72-81. PubMed ID: 30463788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer.
    Day F; Muranyi A; Singh S; Shanmugam K; Williams D; Byrne D; Pham K; Palmieri M; Tie J; Grogan T; Gibbs P; Sieber O; Waring P; Desai J
    Target Oncol; 2015 Mar; 10(1):99-109. PubMed ID: 24859797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic Features and Prognosis of
    Guan WL; Qiu MZ; He CY; Yang LQ; Jin Y; Wang ZQ; Li YH; Xu RH; Wang FH
    Front Oncol; 2020; 10():563407. PubMed ID: 33330032
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan.
    Ikoma T; Shimokawa M; Kotaka M; Matsumoto T; Nagai H; Boku S; Shibata N; Yasui H; Satake H
    BMC Cancer; 2021 May; 21(1):518. PubMed ID: 33962575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway.
    Liu M; Xu X; Peng K; Hou P; Yuan Y; Li S; Sun X; Shi Z; Zhang J; Dong Y; Liu Q; Ai L; Liang L; Gan L; Huang Q; Yu Y; Liu T
    Oncogenesis; 2022 Sep; 11(1):58. PubMed ID: 36130926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer.
    Nakaji Y; Oki E; Nakanishi R; Ando K; Sugiyama M; Nakashima Y; Yamashita N; Saeki H; Oda Y; Maehara Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):151-160. PubMed ID: 27672042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer.
    Matsumoto A; Shimada Y; Nakano M; Oyanagi H; Tajima Y; Nakano M; Kameyama H; Hirose Y; Ichikawa H; Nagahashi M; Nogami H; Maruyama S; Takii Y; Ling Y; Okuda S; Wakai T
    Oncol Rep; 2020 Jun; 43(6):1853-1862. PubMed ID: 32236609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation.
    Tie J; Gibbs P; Lipton L; Christie M; Jorissen RN; Burgess AW; Croxford M; Jones I; Langland R; Kosmider S; McKay D; Bollag G; Nolop K; Sieber OM; Desai J
    Int J Cancer; 2011 May; 128(9):2075-84. PubMed ID: 20635392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic pattern is a prognostic factor in BRAF
    Ji J; Sandhu J; Wang C; Fakih M
    Cancer Treat Res Commun; 2023; 35():100714. PubMed ID: 37126990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS.
    Cannon TL; Randall JN; Sokol ES; Alexander SM; Wadlow RC; Winer AA; Barnett DM; Rayes DL; Nimeiri HS; McGregor KA
    Cancer Treat Res Commun; 2022; 32():100569. PubMed ID: 35567913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.
    Jo YS; Li S; Song JH; Kwon KH; Lee JC; Rha SY; Lee HJ; Sul JY; Kweon GR; Ro HK; Kim JM; Shong M
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3667-70. PubMed ID: 16772349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF(V600E) mutation is not a positive predictor for distant metastasis in sporadic papillary thyroid carcinoma.
    Jing FJ; Liang J; Liang ZY; Meng C; Long W; Li XY; Lin YS
    Chin Med J (Engl); 2013 Aug; 126(16):3013-8. PubMed ID: 23981603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological Significance of
    Wang J; Shen J; Huang C; Cao M; Shen L
    J Cancer; 2019; 10(10):2332-2341. PubMed ID: 31258736
    [No Abstract]   [Full Text] [Related]  

  • 16. MAPK inhibitors induce serine peptidase inhibitor Kazal type 1 (SPINK1) secretion in BRAF V600E-mutant colorectal adenocarcinoma.
    Räsänen K; Dang KX; Mustonen H; Ho TH; Lintula S; Koistinen H; Stenman UH; Haglund C; Stenman J
    Mol Oncol; 2018 Feb; 12(2):224-238. PubMed ID: 29193645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yes-activated protein promotes primary resistance of
    Su M; Zhan L; Zhang Y; Zhang J
    J Gastrointest Oncol; 2021 Jun; 12(3):953-963. PubMed ID: 34295548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF
    Trivieri N; Pracella R; Cariglia MG; Panebianco C; Parrella P; Visioli A; Giani F; Soriano AA; Barile C; Canistro G; Latiano TP; Dimitri L; Bazzocchi F; Cassano D; Vescovi AL; Pazienza V; Binda E
    J Exp Clin Cancer Res; 2020 Dec; 39(1):285. PubMed ID: 33317591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
    Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status.
    Jang MH; Kim S; Hwang DY; Kim WY; Lim SD; Kim WS; Hwang TS; Han HS
    J Korean Med Sci; 2017 Jan; 32(1):38-46. PubMed ID: 27914130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.